Yantacaw Capital
Venture fund · from SEC filings

MPM Bio 2014 NVS Strategic Fund, L.P.

MPM BioImpact · adviser of record: MPM Asset Management LLC · 2014 vintage

MPM Bio 2014 NVS Strategic Fund, L.P. is a 2014 venture fund managed by MPM BioImpact, with $22.5mm raised (Form D, amount sold). It reported $7.2mm in gross assets at year-end 2023, 0.32x its size, against a peak of $53.2mm in 2018.

Latest value held
$7.2mm year-end 2023
Peak
$53.2mm year-end 2018
Fund size
$22.5mm Form D, amount sold
Held vs. size
0.32x peak 2.37x

Value held by year-end

$20mm$40mm$60mm2014201520162017201820192020202120222023

Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker

Year-endGross assets÷ sizeChange
2023$7.2mm0.32x-74%
2022$27.6mm1.23x-41%
2021$46.7mm2.08x+72%
2020$27.1mm1.21x-34%
2019$41.3mm1.84x-22%
2018$53.2mm2.37x+26%
2017$42.2mm1.87x+50%
2016$28.2mm1.25x+30%
2015$21.6mm0.96x-1%
2014$21.8mm0.97x–

Other funds from MPM BioImpact

All MPM BioImpact funds

About these numbers

Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-4551094035. Data updated October 13, 2026.

Is this your fund?

Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.